Letter from the Executive Committee
We write to alert you to activities of the Division for Cancer Pharmacology (DCP), the latest member division of The American Society for Pharmacology and Experimental Therapeutics (ASPET) and, if you haven’t already done so, to encourage you and other colleagues to join ASPET and the new cancer pharmacology division. Learn more about ASPET’s membership benefits. When applying for membership, you may choose Cancer Pharmacology as either your primary or one of your secondary Divisions.
Since its formation two years ago, DCP is emerging as the ‘go-to’ place for cancer pharmacologists to gather at the ASPET Annual Meeting at Experimental Biology (EB) to present their latest findings in all aspects of cancer pharmacology. The ASPET Annual Meeting also provides an excellent forum for building professional networks and forming collaborations with colleagues from across the continent. The next ASPET Annual Meeting at EB is April 22-26, 2017 in Chicago, IL. We hope you will plan to attend.
The ASPET Annual Meeting at EB is the place to participate in outstanding DCP-sponsored Symposia on topics related to both basic and translational aspects of cancer therapeutics. DCP is unique in the cancer research community in strongly promoting member-initiated Symposia, where the choice of speakers and topics are based on applications submitted by members. This mechanism provides a fabulous venue for highlighting the latest developments in cancer pharmacology and promoting the career development of junior faculty. We encourage you to consider submitting proposals for future Symposia. The EB 2018 ASPET meeting is April 21-25, 2018 in San Diego, CA. The deadline for proposals for the 2018 meeting is March 16, 2017.
DCP also offers multiple opportunities at the ASPET Annual Meeting for trainees and junior investigators to present their work at platform symposia, to participate in poster competitions (with monetary awards), and to network with other trainees as well as established scientists in their field. We hope you will encourage trainees at your institution to submit abstracts and attend this meeting. Please note that trainees are eligible for ASPET travel awards.
Please help us spread the word about DCP and share this information with colleagues interested in all aspects of Cancer Pharmacology. Learn more on the DCP website.
Susan P.C. Cole, PhD, FRSC
Professor and Bracken Chair in Genetics & Molecular Medicine
Division of Cancer Biology & Genetics Toxicology
Queen’s University Cancer Research Institute
Mary-Ann Bjornsti, PhD
Professor and Chair,
Department of Pharmacology & Toxicology
University of Alabama at Birmingham
R. Kip Guy, PhD
Dean, College of Pharmacy,
University of Kentucky
Jack C. Yalowich, PhD
Professor and Chair,
Division of Pharmacology
The Ohio State University
Download the letter in PDF.
Last updated: January 25, 2017